Post-approval studies (Phase 4)Ended earlyNCT04877457
What this trial is testing
Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.
Who this might be right for
Radiologically Isolated SyndromeMultiple Sclerosis
Yale University 3